Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Remuñán-López C[au]:

Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Mosaeilhy A et al. Metab Brain Dis. (2017)

Essential role of HDAC6 in the regulation of PD-L1 in melanoma. M L et al. Mol Oncol. (2016)

Insights into dovetailing GTD and Cancers. Nadhan R et al. Crit Rev Oncol Hematol. (2017)

Search results

Items: 33

1.

Transfection of pulmonary cells by stable pDNA-polycationic hybrid nanostructured particles.

Gaspar DP, Vital J, Leiva MC, Gonçalves LM, Taboada P, Remuñán-López C, Vítor J, Almeida AJ.

Nanomedicine (Lond). 2019 Feb;14(4):407-429. doi: 10.2217/nnm-2018-0270. Epub 2019 Jan 30.

PMID:
30698066
2.

Delimiting the knowledge space and the design space of nanostructured lipid carriers through Artificial Intelligence tools.

Rouco H, Diaz-Rodriguez P, Rama-Molinos S, Remuñán-López C, Landin M.

Int J Pharm. 2018 Dec 20;553(1-2):522-530. doi: 10.1016/j.ijpharm.2018.10.058. Epub 2018 Oct 26.

PMID:
30442594
3.

Micro/nanostructured inhalable formulation based on polysaccharides: Effect of a thermoprotectant on powder properties and protein integrity.

Al-Qadi S, Taboada P, Remuñán-López C.

Int J Pharm. 2018 Nov 15;551(1-2):23-33. doi: 10.1016/j.ijpharm.2018.08.049. Epub 2018 Aug 25.

PMID:
30153489
4.

Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.

Gaspar DP, Gaspar MM, Eleutério CV, Grenha A, Blanco M, Gonçalves LMD, Taboada P, Almeida AJ, Remuñán-López C.

Mol Pharm. 2017 Sep 5;14(9):2977-2990. doi: 10.1021/acs.molpharmaceut.7b00169. Epub 2017 Aug 15.

PMID:
28809501
5.

Freeze-dried cylinders carrying chitosan nanoparticles for vaginal peptide delivery.

Marciello M, Rossi S, Caramella C, Remuñán-López C.

Carbohydr Polym. 2017 Aug 15;170:43-51. doi: 10.1016/j.carbpol.2017.04.051. Epub 2017 Apr 23.

PMID:
28522002
6.

Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.

Gaspar DP, Serra C, Lino PR, Gonçalves L, Taboada P, Remuñán-López C, Almeida AJ.

Int J Pharm. 2017 Jan 10;516(1-2):231-246. doi: 10.1016/j.ijpharm.2016.11.037. Epub 2016 Nov 15.

PMID:
27864069
7.

Physical Properties and Stability of Soft Gelled Chitosan-Based Nanoparticles.

Goycoolea FM, Brunel F, Gueddari NE, Coggiola A, Lollo G, Moerschbacher BM, Remuñán-López C, Delair T, Domard A, Alonso MJ.

Macromol Biosci. 2016 Dec;16(12):1873-1882. doi: 10.1002/mabi.201600298. Epub 2016 Oct 27.

8.

The role of hyaluronic acid inclusion on the energetics of encapsulation and release of a protein molecule from chitosan-based nanoparticles.

Al-Qadi S, Alatorre-Meda M, Martin-Pastor M, Taboada P, Remuñán-López C.

Colloids Surf B Biointerfaces. 2016 May 1;141:223-232. doi: 10.1016/j.colsurfb.2016.01.029. Epub 2016 Jan 21.

PMID:
26854581
9.

Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.

Gaspar DP, Faria V, Gonçalves LM, Taboada P, Remuñán-López C, Almeida AJ.

Int J Pharm. 2016 Jan 30;497(1-2):199-209. doi: 10.1016/j.ijpharm.2015.11.050. Epub 2015 Nov 30.

PMID:
26656946
10.

Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation.

Rodrigues S, Cordeiro C, Seijo B, Remuñán-López C, Grenha A.

Carbohydr Polym. 2015 Jun 5;123:369-80. doi: 10.1016/j.carbpol.2015.01.048. Epub 2015 Feb 3.

PMID:
25843870
11.

Development of PLGA-mannosamine nanoparticles as oral protein carriers.

Alonso-Sande M, des Rieux A, Fievez V, Sarmento B, Delgado A, Evora C, Remuñán-López C, Préat V, Alonso MJ.

Biomacromolecules. 2013 Nov 11;14(11):4046-52. doi: 10.1021/bm401141u. Epub 2013 Oct 30.

PMID:
24131254
12.

Pullulan-based nanoparticles as carriers for transmucosal protein delivery.

Dionísio M, Cordeiro C, Remuñán-López C, Seijo B, Rosa da Costa AM, Grenha A.

Eur J Pharm Sci. 2013 Sep 27;50(1):102-13. doi: 10.1016/j.ejps.2013.04.018. Epub 2013 Apr 25.

PMID:
23624352
13.

Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.

Al-Qadi S, Alatorre-Meda M, Zaghloul EM, Taboada P, Remunán-López C.

Colloids Surf B Biointerfaces. 2013 Mar 1;103:615-23. doi: 10.1016/j.colsurfb.2012.11.009. Epub 2012 Nov 23.

PMID:
23274155
14.

Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.

Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C.

J Control Release. 2012 Feb 10;157(3):383-90. doi: 10.1016/j.jconrel.2011.08.008. Epub 2011 Aug 12.

PMID:
21864592
15.

Mucosal delivery of liposome-chitosan nanoparticle complexes.

Carvalho EL, Grenha A, Remuñán-López C, Alonso MJ, Seijo B.

Methods Enzymol. 2009;465:289-312. doi: 10.1016/S0076-6879(09)65015-1.

PMID:
19913173
16.

Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules.

Goycoolea FM, Lollo G, Remuñán-López C, Quaglia F, Alonso MJ.

Biomacromolecules. 2009 Jul 13;10(7):1736-43. doi: 10.1021/bm9001377. Epub 2009 Jun 22.

PMID:
19545119
17.

New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.

Teijeiro-Osorio D, Remuñán-López C, Alonso MJ.

Biomacromolecules. 2009 Feb 9;10(2):243-9. doi: 10.1021/bm800975j.

PMID:
19117404
18.

Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.

Teijeiro-Osorio D, Remuñán-López C, Alonso MJ.

Eur J Pharm Biopharm. 2009 Feb;71(2):257-63. doi: 10.1016/j.ejpb.2008.09.020. Epub 2008 Oct 14.

PMID:
18955137
19.

Glucomannan, a promising polysaccharide for biopharmaceutical purposes.

Alonso-Sande M, Teijeiro-Osorio D, Remuñán-López C, Alonso MJ.

Eur J Pharm Biopharm. 2009 Jun;72(2):453-62. doi: 10.1016/j.ejpb.2008.02.005. Epub 2008 Feb 16.

PMID:
18511246
20.
21.

Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.

Grenha A, Remuñán-López C, Carvalho EL, Seijo B.

Eur J Pharm Biopharm. 2008 May;69(1):83-93. doi: 10.1016/j.ejpb.2007.10.017. Epub 2007 Nov 4.

PMID:
18166446
22.

Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization.

Grenha A, Seijo B, Serra C, Remuñan-López C.

Biomacromolecules. 2007 Jul;8(7):2072-9. Epub 2007 Jun 22.

PMID:
17585804
23.

Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.

Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remuñán-López C, Forbes B.

Eur J Pharm Sci. 2007 Jun;31(2):73-84. Epub 2007 Feb 25.

PMID:
17408932
24.

Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery.

Cuña M, Alonso-Sandel M, Remuñán-López C, Pivel JP, Alonso-Lebrero JL, Alonso MJ.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2887-95.

PMID:
17048495
25.

Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.

Anal AK, Stevens WF, Remuñán-López C.

Int J Pharm. 2006 Apr 7;312(1-2):166-73. Epub 2006 Feb 23.

PMID:
16497452
26.

Microencapsulated chitosan nanoparticles for lung protein delivery.

Grenha A, Seijo B, Remuñán-López C.

Eur J Pharm Sci. 2005 Jul-Aug;25(4-5):427-37.

PMID:
15893461
27.

Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa.

Portero A, Remuñán-López C, Criado MT, Alonso MJ.

J Microencapsul. 2002 Nov-Dec;19(6):797-809.

PMID:
12569028
28.
29.

Enhancement of nasal absorption of insulin using chitosan nanoparticles.

Fernández-Urrusuno R, Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ.

Pharm Res. 1999 Oct;16(10):1576-81.

PMID:
10554100
30.

Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery.

Remuñán-López C, Portero A, Vila-Jato JL, Alonso MJ.

J Control Release. 1998 Nov 13;55(2-3):143-52.

PMID:
9795035
31.

Development of new chitosan-cellulose multicore microparticles for controlled drug delivery.

Remuñán-López C, Lorenzo-Lamosa ML, Vila-Jato JL, Alonso MJ.

Eur J Pharm Biopharm. 1998 Jan;45(1):49-56.

PMID:
9689535
32.

Design of microencapsulated chitosan microspheres for colonic drug delivery.

Lorenzo-Lamosa ML, Remuñán-López C, Vila-Jato JL, Alonso MJ.

J Control Release. 1998 Mar 2;52(1-2):109-18.

PMID:
9685941
33.

Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines.

Calvo P, Remuñan-López C, Vila-Jato JL, Alonso MJ.

Pharm Res. 1997 Oct;14(10):1431-6.

PMID:
9358557

Supplemental Content

Loading ...
Support Center